Walden Group Healthcare M&A Blog

  • TopCon Acquires Italy-based Ophthalmic Imaging Device Producer VISIA Imaging

    TopCon Corporation, a $1.2 billion Japan-based developer of eyecare devices and software solutions worldwide has purchased Italy-based ophthalmic device manufacturer VISIA Imaging S.r.l.  The acquisition provides Topcon with a portfolio of imaging devices focused on the anterior segment to complement its existing posterior segment imaging...
    Read More
  • Surmodics Acquires Ireland–based Vetex Medical

    Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found...
    Read More
  • Tecan Group Acquires Paramit for $1b

    Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan's entry into medical devices and enhances Paramit's...
    Read More
  • DENTSPLY SIRONA Inc. Acquires Propel Orthodontics for $131M

    DENTSPLY SIRONA (Nasdaq: XRAY), a $3.3b provider of dental technologies, equipment and consumables has acquired Propel Orthodontics, developer of the VPro, a vibratory orthodontic device that seats aligners in 5 minutes a day for at-home use.  The VPro device is used with Propel’s Fastrack Mobile App that patients can use to track usage and...
    Read More
  • Japan-based Olympus Corporation Acquires Israel-based Medi-Tate

    Adds an in-office treatment for benign prostatic hyperplasia (BPH) treatment to Olympus’ leading urological devices portfolio.  Medi-Tate's “iTind” has received FDA de Novo authorization and a European CE mark.  Since November 2018, Olympus secured distribution rights to iTind via an initial investment.  The incidence of BPH is one of...
    Read More